Bone Loss in Lymphoma Patients Prior to Receiving Front-line Therapy

被引：2

作者：

Westin, Jason R. ^{[1
]}

Thompson, Michael A. ^{[2
]}

Cataldo, Vince D. ^{[3
]}

Toth, Bela B. ^{[4
]}

Sanjorjo, Perpetua ^{[5
]}

Bourgeois, Scott ^{[5
]}

Jimenez, Camilo ^{[6
]}

Murphy, William A. ^{[7
]}

Fanale, Michelle ^{[5
]}

Fayad, Luis ^{[5
]}

Fowler, Nathan ^{[5
]}

Kwak, Larry ^{[5
]}

McLaughlin, Peter ^{[5
]}

Neelapu, Sattva ^{[5
]}

Pro, Barbara ^{[5
]}

Rodriguez, Alma ^{[5
]}

Shah, Jatin ^{[5
]}

Hagemeister, Fredrick B. ^{[5
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA

[2] Waukesha Mem Hosp, ProHlth Care Canc Ctr, Waukesha, WI USA

[3] Louisiana State Univ, New Orleans, LA USA

[4] Univ Texas MD Anderson Canc Ctr, Dept Dent Oncol, Houston, TX 77030 USA

[5] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA

[6] Univ Texas MD Anderson Canc Ctr, Dept Endocrine Neoplasia & Hormonal Disorders, Houston, TX 77030 USA

[7] Univ Texas MD Anderson Canc Ctr, Dept Diagnost Radiol, Houston, TX 77030 USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2010年 / 10卷 / 03期

关键词：

D O I：

10.3816/CLML.2010.n.042

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：E32 / E32

页数：1

共 50 条

[31] The role of autologous stem cell transplantation as front-line therapy in poems patients
De Matteis, S.
Laurenti, L.
Chiusolo, P.
Reddiconto, G.
Bellesi, S.
Sora, F.
Giammarco, S.
Sica, S.
Leone, G.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 252 - 253
[32] Front-line therapy in lung cancer with mutations in EGFR
Lorenza Landi
Federico Cappuzzo
Nature Reviews Clinical Oncology, 2011, 8 : 571 - 573
[33] Hopes and failures in front-line ovarian cancer therapy
Tsibulak, Irina
Zeimet, Alain G.
Marth, Christian
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2019, 143 : 14 - 19
[34] Front-line therapy in polycythemia vera and essential thrombocythemia
Barbui, Tiziano
Finazzi, Maria Chiara
Finazzi, Guido
BLOOD REVIEWS, 2012, 26 (05) : 205 - 211
[35] Metastatic breast cancer—optimal front-line therapy
Vessela Vassileva
Nature Reviews Clinical Oncology, 2009, 6 (10) : 557 - 557
[36] Future perspectives of docetaxel (Taxotere) in front-line therapy
Piccart, MJ
DiLeo, A
SEMINARS IN ONCOLOGY, 1997, 24 (04) : 27 - 33
[37] Front-line therapy in lung cancer with mutations in EGFR
Landi, Lorenza
Cappuzzo, Federico
NATURE REVIEWS CLINICAL ONCOLOGY, 2011, 8 (10) : 571 - 573
[38] Bortezomib and lenalidomide as front-line therapy for multiple myeloma
Zou, Yandun
Lin, Mingzhen
Sheng, Zhixin
Niu, Shaona
LEUKEMIA & LYMPHOMA, 2014, 55 (09) : 2024 - 2031
[39] Pathophysiology of bone loss in patients receiving anticonvulsant therapy
Fitzpatrick, LA
EPILEPSY & BEHAVIOR, 2004, 5 : S3 - S15
[40] Outcomes for Relapsed and Refractory Peripheral T-Cell Lymphoma Patients after Front-Line Therapy from the COMPLETE Registry
Lansigan, Frederick
Horwitz, Steven M.
Pinter-Brown, Lauren C.
Rosen, Steven T.
Pro, Barbara
Hsi, Eric D.
Federico, Massimo
Gisselbrecht, Christian
Schwartz, Marc
Bellm, Lisa A.
Acosta, Mark
Shustov, Andrei R.
Advani, Ranjana H.
Feldman, Tatyana
Lechowicz, Mary Jo
Smith, Sonali M.
Tulpule, Anil
Craig, Michael D.
Greer, John P.
Kahl, Brad S.
Leach, Joseph W.
Morganstein, Neil
Casulo, Carla
Park, Steven, I
Foss, Francine M.
ACTA HAEMATOLOGICA, 2020, 143 (01) : 40 - 50

← 1 2 3 4 5 →